ALGINATE/ANTACID IN THE REDUCTION OF GASTRO-$OElig;SOPHAGEAL REFLUX

Stanciu, C; Bennett, J. R.

doi:10.1016/s0140-6736(74)92340-x

Cited by 122 publications

(29 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Antacids (60) and alginic acid (61,62) have been shown to be more effective than placebo in the relief of symptoms induced by a heartburn promoting meal. In addition, combined antacid/alginic acid therapy may be superior to antacids alone in the control of symptoms (63,64). There are two long-term trials, which suggest effective symptom relief in approximately 20% of patients using OTC agents (65,66).…”

Section: Level Of Evidence: IVmentioning

confidence: 99%

Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

DeVault

Castell

2005

Am J Gastroenterology

789

491

View full text Add to dashboard Cite

Section: Level Of Evidence: IVmentioning

confidence: 99%

Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

DeVault

Castell

2005

Am J Gastroenterology

789

491

View full text Add to dashboard Cite

“…Antacids (51) and alginic acid (52,53) have been shown to be more effective than placebo in the relief of symptoms induced by a heartburn-promoting meal. In addition, combined antacid/ alginic acid therapy may be superior to antacids alone in the control of symptoms (54,55). There are two long-term trials that suggest effective symptom relief in approximately 20% of patients using over-the-counter agents (56,57).…”

Section: No Change Lifestyle Modification Should Be Initiated and Conmentioning

confidence: 99%

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease

DeVault¹

1999

The American Journal of Gastroenterology

143

178

View full text Add to dashboard Cite

PREAMBLEGuidelines for the diagnosis and treatment of gastroesophageal reflux disease (GERD) were published by the American College of Gastroenterology in 1995 (1). These and other guidelines undergo periodic review. Significant advances have been made in the area of GERD over the past several years, leading us to review and revise our previous guidelines statements. These advances have included an increase in our comfort with the chronic use of proton pump inhibitors and an increased acceptance of laparoscopic antireflux surgery, among other factors. These and the original guidelines are intended to apply to all physicians who address GERD and are intended to indicate the preferable, but not only acceptable, approach. Physicians must always choose the course best suited to the individual patient and the variables that exist at the moment of the decision. These guidelines are intended to apply to adult patients with the symptoms, tissue damage, or both that result from the reflux of gastric contents into the esophagus. For the purpose of these guidelines GERD is defined as chronic symptoms or mucosal damage produced by the abnormal reflux of gastric contents into the esophagus.Both these and the original guidelines were developed under the auspices of the American College of Gastroenterology and its Practice Parameters Committee, and approved by the Board of Trustees. The world literature was reviewed extensively for the original guidelines and was once again reviewed using the National Library of Medicine database. All appropriate studies were reviewed and any additional studies found in the reference list of these papers were obtained and reviewed. Evidence was evaluated along a hierarchy, with randomized controlled trials given the greatest weight. Abstracts presented at national and international meetings were only used when unique data from ongoing trials were presented. When scientific data were lacking, recommendations were based on expert consensus. During preparation, the guidelines were reviewed

show abstract

“…These drugs are effective in the treatment of esophagitis and relief of heartburn. The presence of simethicone, dimethicone, or alginates may be additionally protective [36,37]. The usual dose of aluminum and magnesium compounds is 30 to 60 ml/1.73 m 2 /day.…”

Section: Therapeutic Methodsmentioning

confidence: 99%

Gastroesophageal Reflux in Infants and Children

El-Mouzan

1991

Ann Saudi Med

View full text Add to dashboard Cite

ALGINATE/ANTACID IN THE REDUCTION OF GASTRO-$OElig;SOPHAGEAL REFLUX

Cited by 122 publications

References 0 publications

Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

Updated Guidelines for the Diagnosis and Treatment of Gastroesophageal Reflux Disease

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease

Gastroesophageal Reflux in Infants and Children

Contact Info

Product

Resources

About